Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DGKA | P23743 | 1/20 | 0.87 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.69 |
| ▸ | NAAA | Q02083 | 1/20 | 0.65 |
| ▸ | PAM | P19021 | 2/20 | 0.64 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.64 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.64 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.64 |
| ▸ | HTR2C | P28335 | 1/20 | 0.61 |
| ▸ | TSHR | P16473 | 1/20 | 0.60 |
| ▸ | MAPT | P10636 | 1/20 | 0.60 |
| ▸ | LMNA | P02545 | 4/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.58 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.56 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.56 |
| ▸ | MEN1 | O00255 | 1/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8638790 | 1.00 | DGKA (0.87) | DGKADNM1NAAAPAMPRSS1 | |
| SCHEMBL3502231 | 1.00 | DGKA (0.87) | DGKADNM1NAAAPAMPRSS1 | |
| SCHEMBL3502982 | 1.00 | DGKA (0.87) | DGKADNM1NAAAPAMPRSS1 | |
| SCHEMBL3505609 | 1.00 | DGKA (0.87) | DGKADNM1NAAAPAMPRSS1 | |
| SCHEMBL15987825 | 1.00 | DGKA (0.87) | DGKADNM1NAAAPAMPRSS1 | |
| SCHEMBL15879526 | 1.00 | DGKA (0.87) | DGKADNM1NAAAPAMPRSS1 | |
| SCHEMBL15879959 | 1.00 | DGKA (0.87) | DGKADNM1NAAAPAMPRSS1 | |
| SCHEMBL15987674 | 1.00 | DGKA (0.87) | DGKADNM1NAAAPAMPRSS1 | |
| SCHEMBL15879872 | 1.00 | DGKA (0.87) | DGKADNM1NAAAPAMPRSS1 | |
| SCHEMBL3503932 | 1.00 | DGKA (0.87) | DGKADNM1NAAAPAMPRSS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 125 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114507312-B | Interfacial modification viscosity reducer for oil displacement and preparation method and application thereof | 中国石油化工股份有限公司 | 2024-06-11 | — | — | CN | claimed |
| CN-116554849-A | Viscosity-reducing oil-displacing composition and preparation method and application thereof | 中国石油化工股份有限公司 | 2023-08-08 | — | — | CN | claimed |
| EP-4734930-A1 | MIXED COMPOSITIONS COMPRISING 1,3-PROPANEDIOL ESTERS FOR COSMETIC FORMULATIONS IN PARTICULAR | Evonik Operations GmbH (DE) | 2026-05-06 | — | — | EP | disclosed |
| US-20250186319-A1 | ANAPLEROTIC COMPOSITIONS AND USES THEREOF | EXCELLA BIOSCIENTIFIC LTD (IL) | 2025-06-12 | — | — | US | disclosed |
| WO-2025003220-A1 | MIXED COMPOSITIONS COMPRISING 1,3-PROPANEDIOL ESTERS FOR COSMETIC FORMULATIONS IN PARTICULAR | EVONIK OPERATIONS GMBH (DE) | 2025-01-02 | — | — | WO | disclosed |
| US-20240269101-A1 | COMPOSITIONS COMPRISING MEDIUM ODD CHAIN LIPIDS WITH MULTIFUNCTIONAL ACTIVITY TO PREVENT AND TREAT SKIN INFLAMMATION AND AGING | EXCELLA BIOSCIENTIFIC LTD (IL) | 2024-08-15 | — | — | US | disclosed |
| CN-116554849-A | Viscosity-reducing oil-displacing composition and preparation method and application thereof | 中国石油化工股份有限公司 | 2023-08-08 | — | — | CN | disclosed |
| EP-4021916-A1 | 4'-ETHYNYL-2'-DEOXYADENOSINE DERIVATIVES AND THEIR USE IN HIV THERAPY | GlaxoSmithKline Intellectual Property (No. 2) Limited (GB) | 2022-07-06 | — | — | EP | disclosed |
| US-9625631-B2 | Optical compensation film, polarizing plate, and liquid crystal display device | Konica Minolta, Inc. (JP) | 2017-04-18 | — | — | US | disclosed |
| US-9598595-B2 | Retardation film, polarizing plate and liquid crystal display device | Konica Minolta, Inc. (JP) | 2017-03-21 | — | — | US | disclosed |
| US-9563075-B2 | Method for manufacturing liquid crystal display device provided with front plate, and liquid crystal display device provided with front plate | Konica Minolta, Inc. (JP) | 2017-02-07 | — | — | US | disclosed |
| US-20070048461-A1 | HARD COAT FILM, PRODUCTION METHOD OF THE SAME, POLARIZING PLATE AND DISPLAY | KONICA MINOLTA OPTO, INC. (JP) | 2007-03-01 | — | — | US | disclosed |
| US-20070048462-A1 | Cellulose ester film, polarizing plate for in-plane-switching mode display and in-plane-switching mode display using the cellulose ester film | KONICA MINOLTA OPTO, INC. (JP) | 2007-03-01 | — | — | US | disclosed |
| US-20070048459-A1 | Polarizing plate and liquid crystal display apparatus using the same | KONICA MINOLTA OPTO, INC. | 2007-03-01 | — | — | US | disclosed |
| US-20070030417-A1 | Cellulose ester film, polarizing plate and liquid crystal display | KONICA MINOLTA OPTO, INC. (JP) | 2007-02-08 | — | — | US | disclosed |
| US-20070022798-A1 | Method of treating optical film, apparatus of treating optical film, and method of manufacturing optical film | KONICA MINOLTA OPTO, INC. (JP) | 2007-02-01 | — | — | US | disclosed |
| US-20070019133-A1 | Polarizing plate and liquid crystal display device | KONICA MINOLTA OPTO, INC. (JP) | 2007-01-25 | — | — | US | disclosed |
| US-20070009676-A1 | Retardation film, polarizing plate, and liquid crystal display device | KONICA MINOLTA OPTO, INC. (JP) | 2007-01-11 | — | — | US | disclosed |
| US-4477447-A | ANTIBIOTIC, BACTERICIDE | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1984-10-16 | — | — | US | disclosed |
| US-4411883-A | DRY AEROSOLS, PROPYLENE-1,2-DIPELARGONATE | COLGATE-PALMOLIVE COMPANY (US) | 1983-10-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240269101-A1 | COMPOSITIONS COMPRISING MEDIUM ODD CHAIN LIPIDS WITH MULTIFUNCTIONAL ACTIVITY TO PREVENT AND TREAT SKIN INFLAMMATION AND AGING | DGAT2, DAGLA, DGAT1 | DGKA 7/4885DNM1 2429/4885NAAA 208/4885 |
| US-20250186319-A1 | ANAPLEROTIC COMPOSITIONS AND USES THEREOF | OAT, PC, ACAT1 | DGKA 540/4885DNM1 1383/4885NAAA 356/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.